PCVX.NASDAQVaxcyte, INC

Form 4: Vaxcyte COO Sells Shares

Sentiment:

Insider Transaction (Form 4)


Jim Wassil, CHIEF OPERATING OFFICER of Vaxcyte, Inc., sold 2,250 shares of common stock on August 3, 2026.

Summary

  • Option exercise/conversion: acquired 2,250 Common Stock at $5.35 ($12,038) on August 3, 2026; holds 159,791 after (Direct).
  • Open-market sale: disposed of 861 Common Stock at $53.50 ($46,065) on August 3, 2026; holds 158,930 after (Direct).
  • Open-market sale: disposed of 1,389 Common Stock at $54.09 ($75,130) on August 3, 2026; holds 157,541 after (Direct).
  • Option exercise/conversion: disposed of 2,250 Stock Option (right to buy) on August 3, 2026; holds 68,898 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $121,195 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

Jim Wassil — Officer (CHIEF OPERATING OFFICER)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-08-03Option exercise/conversionCommon Stock2,250$5$12.0K159,791
2026-08-03Open-market saleCommon Stock861$54$46.1K158,930
2026-08-03Open-market saleCommon Stock1,389$54$75.1K157,541
2026-08-03Option exercise/conversionStock Option (right to buy)2,250——68,898

Key Dates

DateDescription
2026-08-03Option exercise/conversion (2,250 shares)
2026-08-03Open-market sale (861 shares)
2026-08-03Open-market sale (1,389 shares)
2026-08-03Option exercise/conversion (2,250 shares)

Keywords

insider transaction, Form 4, PCVX, Vaxcyte, Inc., bearish, Jim Wassil

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.